The Neuropeptide CGRP Induces Bipolar Syndrome in Group 2 Innate Lymphoid Cells.
In this issue of Immunity, Nagashima et al., Wallrapp et al., and Xu et al. demonstrate that the neuropeptide calcitonin gene-related peptide (CGRP) fine tunes type 2 innate immune response via suppressing group 2 innate lymphoid cells (ILC2s).